Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study.
Zhang S, Tang K, Wan G, Nguyen N, Lu C, Ugwu-Dike P, Raval N, Seo J, Alexander NA, Jairath R, Phillipps J, Leung BW, Roster K, Chen W, Zubiri L, Boland G, Chen ST, Tsao H, Demehri S, LeBoeuf NR, Reynolds KL, Yu KH, Gusev A, Kwatra SG, Semenov YR. Zhang S, et al. Among authors: leboeuf nr. medRxiv [Preprint]. 2023 Jan 18:2023.01.16.23284635. doi: 10.1101/2023.01.16.23284635. medRxiv. 2023. Update in: J Am Acad Dermatol. 2023 May;88(5):1024-1032. doi: 10.1016/j.jaad.2022.12.048 PMID: 36711758 Free PMC article. Updated. Preprint.
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study.
Wan G, Nguyen N, Leung BW, Rashdan H, Tang K, Roster K, Collier MR, Ugwu-Dike PO, Raval NS, Alexander NA, Jairath R, Phillipps J, Amadife M, Zhang S, Gusev A, Chen ST, Reynolds KL, LeBoeuf NR, Kwatra SG, Semenov YR. Wan G, et al. Among authors: leboeuf nr. medRxiv [Preprint]. 2023 Aug 29:2023.08.28.23294695. doi: 10.1101/2023.08.28.23294695. medRxiv. 2023. Update in: J Am Acad Dermatol. 2024 Feb;90(2):418-420. doi: 10.1016/j.jaad.2023.09.082 PMID: 37693493 Free PMC article. Updated. Preprint.
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study.
Wan G, Khattab S, Leung BW, Zhang S, Nguyen N, Tran M, Lin C, Chang C, Alexander N, Jairath R, Phillipps J, Tang K, Rajeh A, Zubiri L, Chen ST, Demehri S, Yu KH, Gusev A, Kwatra SG, LeBoeuf NR, Reynolds KL, Semenov YR. Wan G, et al. Among authors: leboeuf nr. Br J Dermatol. 2024 Jun 20;191(1):117-124. doi: 10.1093/bjd/ljae053. Br J Dermatol. 2024. PMID: 38366637 Free PMC article.
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.
Sun VH, Heemelaar JC, Hadzic I, Raghu VK, Wu CY, Zubiri L, Ghamari A, LeBoeuf NR, Abu-Shawer O, Kehl KL, Grover S, Singh P, Suero-Abreu GA, Wu J, Falade AS, Grealish K, Thomas MF, Hathaway N, Medoff BD, Gilman HK, Villani AC, Ho JS, Mooradian MJ, Sise ME, Zlotoff DA, Blum SM, Dougan M, Sullivan RJ, Neilan TG, Reynolds KL. Sun VH, et al. Among authors: leboeuf nr. J Clin Oncol. 2024 Dec 10;42(35):4134-4144. doi: 10.1200/JCO.24.00326. Epub 2024 Sep 3. J Clin Oncol. 2024. PMID: 39226489
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.
Wan G, Chen W, Khattab S, Roster K, Nguyen N, Yan B, Rajeh A, Seo J, Rashdan H, Zubiri L, Hadfield MJ, Demehri S, Yu KH, Lotter W, Gusev A, LeBoeuf NR, Reynolds KL, Kwatra SG, Semenov YR. Wan G, et al. Among authors: leboeuf nr. Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15. Lancet Oncol. 2024. PMID: 39025103
146 results